Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CFRX

ContraFect (CFRX) Stock Price, News & Analysis

ContraFect logo

About ContraFect Stock (NASDAQ:CFRX)

Advanced Chart

Key Stats

Today's Range
$0.05
$0.06
50-Day Range
$0.05
$0.07
52-Week Range
$0.04
$13.02
Volume
910,216 shs
Average Volume
1.39 million shs
Market Capitalization
$535 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CFRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ContraFect and its competitors with MarketBeat's FREE daily newsletter.

CFRX Stock News Headlines

22R.BE,0P0001D9RF,0 (22R.BE)
RegenETP, Inc. (RGTPQ)
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
ContraFect Corp CFRXQ
ContraFect Corp CFRX
ContraFect: Q3 Earnings Snapshot
Why Is ContraFect (CFRX) Stock Up 23% Today?
See More Headlines

CFRX Stock Analysis - Frequently Asked Questions

ContraFect Co. (NASDAQ:CFRX) announced its quarterly earnings data on Monday, November, 15th. The biotechnology company reported ($10.40) EPS for the quarter, beating the consensus estimate of ($22.64) by $12.24.

ContraFect shares reverse split before market open on Tuesday, February 14th 2023.The 1-80 reverse split was announced on Tuesday, February 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that ContraFect investors own include SCYNEXIS (SCYX), Inovio Pharmaceuticals (INO), Meta Platforms (META), Tonix Pharmaceuticals (TNXP), Novavax (NVAX), VBI Vaccines (VBIV) and Cidara Therapeutics (CDTX).

Company Calendar

Last Earnings
11/15/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CFRX
CIK
1478069
Fax
N/A
Employees
23
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.15 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($19.92) per share
Price / Book
0.00

Miscellaneous

Free Float
10,639,000
Market Cap
$535 thousand
Optionable
Not Optionable
Beta
0.29

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CFRX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners